Endocrinology

VTE risk with newer hormonal contraceptives
Venous thromboembolism is a recognized adverse event linked to hormonal contraceptives, with an increased risk related to higher estrogen dose and progestin type, in particular depot medroxyprogesterone acetate.
Health Canada approves first pill to treat postpartum depression
Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.

Can’t take hormone therapy for menopause? What are other options?

Beyond lifestyle changes, some nonhormonal prescription medicines have been shown to ease menopausal symptoms.
Does breast cancer risk differ based on hormonal contraceptive ingredients?

Study estimates the difference in breast cancer risk associated with different hormonal contraceptive formulations in adolescents and premenopausal women.
Canadian menopausal hormone therapy dosage equivalency table now available

This new Canadian Menopause Society resource is designed to simplify menopausal hormone therapy and facilitate product comparisons.
Doctors want women to know the nuanced reality of hormone therapy for menopause

Doctors are divided over whether there should be changes in ‘black box’ health warnings on some hormone treatments.
Menopausal hormone therapy reduces fracture risk, even in the long term: study

Researchers analyzed the medical records of more than three million women aged 40 and over.
Act quickly: a pharmacist's guide to emergency contraception

Key considerations for pharmacists providing EC.
PCOS is a big threat to women’s health, but it’s still under-recognized, under-diagnosed and under-treated

Cardiovascular disease is the leading cause of death worldwide, so when PCOS symptoms are missed and untreated, women’s health is at risk.
Progestin-only birth control pill increases risk of asthma attacks

Use of the contraceptives exposed women under 35 to a 39% greater risk of asthma attacks, likely due to an excess of the hormone from combined endogenous and exogenous progesterone.

VTE risk with newer hormonal contraceptives

Health Canada approves first pill to treat postpartum depression

Can’t take hormone therapy for menopause? What are other options?

Does breast cancer risk differ based on hormonal contraceptive ingredients?

Canadian menopausal hormone therapy dosage equivalency table now available

Doctors want women to know the nuanced reality of hormone therapy for menopause

Menopausal hormone therapy reduces fracture risk, even in the long term: study

Act quickly: a pharmacist's guide to emergency contraception

PCOS is a big threat to women’s health, but it’s still under-recognized, under-diagnosed and under-treated

Progestin-only birth control pill increases risk of asthma attacks